Abstract
The aim of our study is to describe the characteristics of patients infected by MPXV in our setting, determine the prevalence of MPXV in samples which are classically used for diagnosing sexually transmitted infections (STIs) such as anal, urethral, pharyngeal and urine, and assess the prevalence of coinfection with STIs in the same samples. A cross-sectional study was conducted, collecting all confirmed cases of MPXV between June and July 2022 using polymerase chain reaction (PCR). Sociodemographic data, HIV and other STIs status, prevalence of MPXV and STIs in urethral, anal, pharyngeal or urine samples, were collected. Data from 22 patients were extracted, all of whom were MSM and 54,5% were previously HIV positive. The median age was 43 years. All the skin samples were positive for MPXV, followed by anal samples (n = 10) (45,5%). MPXV was isolated in 2 or more samples simultaneously in 12 (54%) cases. 9 (41%) patients were positive for an STI and 4 of them had more than one STI (18,2%). Human monkeypox has been epidemiologically significant among MSM. MPXV should be investigated not only in skin lesions but also in samples classically used for STI. MPXV, like other STIs, share ways of transmission and coinfection may be underdiagnosed.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call